GALNT2 and lung adenocarcinoma: In addition, the expression of GALNT2 was also upregulated in various cancer types, such as breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), head-neck squamous cell carcinoma (HNSC), kidney renal clear cell carcinoma (KIRC), lung adenocarcinoma (LUAD), lung squamous cell carcinoma (LUSC) and stomach adenocarcinoma (STAD) (Supplementary Figure S1D).